Evaluation of kanamycin in a triple regimen of kanamycin, cycloserine and ethionamide in the treatment of far-advanced cases of pulmonary tuberculosis with tubercle bacilli resistant to primary drugs.
D000328:Adult; D003523:Cycloserine / Q000008:administration & dosage*; D004352:Drug Resistance, Microbial; D005000:Ethionamide / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007612:Kanamycin / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D009169:Mycobacterium tuberculosis / Q000187:drug effects; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D007612:Kanamycin; D003523:Cycloserine; D005000:Ethionamide